One possible explanation for this lack of potency in AML is that BM-infiltrating T cells in AML expressing various inhibitory receptors, such as TIM-3 and lymphocyte-activation gene 3 (LAG-3). This evidence concerns the gene HAVCR2 and acute myeloid leukemia.